Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin
CD59, kininogen-1 and fragments of ITIH4 and albumin may be used as complementary biomarkers in the development of new noninvasive protocols for diagnosis and screening of ovarian carcinoma.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
BMC
2010
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/1322/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998473/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|